FDA APPROVAL PENDING
Moderate Research
Sexual
Prostamax
4
Amino acids
Molecular weight
Peptide
Type
Prostamax is a Khavinson bioregulator tetrapeptide (KEDP) with primary repair effects on prostate tissue. Developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, it alters chromatin structure in cells from elderly individuals, promoting deheterochromatinization and potentially reactivating genes repressed during aging. Research in rat models shows reduced prostate inflammation, decreased swelling, and decelerated pathological remodeling associated with prostatitis.
Prostamax works through epigenetic regulation by altering chromatin structure. It increases the frequency of sister chromatid exchanges and Ag-positive nucleolar organizer regions (NORs), while reducing large segments of pericentromeric heterochromatin. These changes promote chromatin decondensation and deheterochromatinization, potentially reactivating genes repressed during aging. The peptide influences heterochromatin arrangements in human lymphocytes and normalizes age-related changes in cellular function.
Capsules at room temperature; reconstituted injectable at 2-8°C refrigerated
Daily for 10-20 days per cycle
10-20mg daily
10-20 days
Reduces prostate inflammation
Decreases prostatic swelling
Reduces vascular congestion (hyperemia)
Decreases immune cell infiltration
Reduces scarring in prostate tissue
Promotes chromatin decondensation
Reactivates age-repressed genes
Improves lymphocyte function
This peptide is still gaining traction in the community.
KEDP Tetrapeptide | Prostate Bioregulator
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesView the scientifc details of Prostamax.
4
Amino Acids
Prostamax
Lys
Lys
Position 1
Glu
Glu
Position 2
Asp
Asp
Position 3
Pro
Pro
Position 4
Available in capsule form for oral administration. Short peptides can be absorbed orally and reach target tissues. Typical protocol involves 10-20 day cycles.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| Standard protocol | 10 | 10 week range | Oral capsules |
| Maintenance | 10 | 2 week range | Oral capsules |
The Prostamax Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
Dosing tools
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Based on your vial and dilution inputs.
Safe concentration range
Prostamax
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg Prostamax vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Note: Triple agonist; microdose for fewer side effects
Research suggestions of Prostamax interactions with other common peptides and substances.
Longevity
cry
Immunity
COMPATIBLE
Part of Khavinson bioregulator family; targets different tissue.
Longevity
epi
Immunity
SYNERGISTIC
Often combined in comprehensive anti-aging Khavinson protocols.
Longevity
test
Sexual
SYNERGISTIC
Complementary male reproductive bioregulators; different tissue targets.
Longevity
vil
Immunity
COMPATIBLE
Different organ targets; can be used in comprehensive bioregulator protocols.
Prostate cancer (consult oncologist)
Known hypersensitivity
Pregnancy (not applicable)
Allergic reactions
Unusual urinary symptoms
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
Prostamax is a moderate research compound
Prostamax
Prostamax is a moderate research compound
Experimental Studying of Drug Efficiency Prostamax in Therapy of Chronic Aseptic Prostatitis
Prostamax reduced prostate swelling, inflammation, and scarring in rat prostatitis models.
n.d.
Effects of Short Peptides on Lymphocyte Chromatin in Senile Subjects
KEDP peptide alters chromatin structure, promoting deheterochromatinization in elderly cells.
n.d.
Deheterochromatinization of Chromatin in Old Age Induced by Oligopeptide Bioregulator (Lys-Glu-Asp-Pro)
Prostamax promotes chromatin decondensation and reactivates age-repressed genes.
n.d.
Khavinson Peptide Bioregulators
Comprehensive review of bioregulator peptides and their epigenetic mechanisms.
n.d.